Don’t miss the Official launch of the NHMRC-funded program to eliminate hepatitis C in Australia!

Join community leaders, experts and policy makers to discuss current approaches and challenges to the elimination of viral hepatitis.

Eliminating viral hepatitis in Australia is now possible with access to testing, treatment and care, and a new, highly effective hepatitis B vaccine.

Hepatitis B and C affects more than 250,000 and 200,000 Australians, respectively, and are major contributors to deaths caused by liver cancer, liver failure and liver transplantation.

Globally, more than one million people die from viral hepatitis-related causes each year.

This year’s symposium will address local and global priorities, and build upon ground-breaking biomedical research, modelling and analysis that demonstrates the feasibility and public health benefit of eliminating viral hepatitis. There will be a particular focus on hepatitis C testing strategies and partnership approaches required to improve care.

Guest speakers will include Burnet Institute’s leading HCV researchers and clinicians, collaborating partners, government, members of the community and affected populations.

Opening and Closing Address:

• Associate Professor Heidi Drummer, Burnet Institute

Speakers:

• Professor Alex Thompson, St Vincent’s Hospital

• Dr Alisa Pedrana, Burnet Institute

• Associate Professor Ben Cowie, Doherty Institute

• Mr Chad Hughes, Burnet Institute

• Mr Charles Henderson, Harm Reduction Victoria

• Dr Fran Bramwell, Healthworks

• Mr Huy Van, Burnet Institute

• Dr Jacqui Richmond, Eliminate Hep C Partnership

• Dr Bridget Williams, Burnet Institute

• Dr Joseph Doyle, Burnet Institute, The Alfred hospital and Monash University

• Professor Margaret Hellard, Burnet Institute

• Ms Melanie Eagle, Hepatitis Victoria

• Dr Peter Higgs, La Trobe University and Burnet Institute

FREE event. Registration essential.